NCT05136625

Sphenopalatine Ganglion Block and Pain Management in Neurosurgery

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 84 (estimated)
• Sponsor: University Hospital of Ferrara · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Post craniotomy pain is defined as headache developed up to 7 days from a craniotomy, not otherwise explained. A moderate to severe pain affects from 60 to 84% of patients. Sphenopalatine ganglion block has been successfully used in patients with chronic or acute headache, facial pain and for transsphenoidal pituitary and endoscopic sinus surgeries. There are evidences that sphenopalatine ganglion block reduces vegetative responses to skull pin closure. This study aim to investigate feasibility and efficacy of sphenopalatine ganglion block in reducing pain after a neurosurgical supratentorial craniotomy.

Conditions

• Post Operative Pain
• Craniofacial Pain

Interventions

Type	Name	Description
DRUG	Sphenopalatine ganglion block	A cotton swab soaked in levobupivacaine 7,5% in inserted into the nose to block sphenopalatine ganglion, with the classic technique previously described
DRUG	Standard Preparation	Troncular scalp blockade. Local site infiltration

Timeline

• Start date: 2021-02-01
• Primary completion: 2024-01-31
• Completion: 2024-06-30
• First posted: 2021-11-29
• Last updated: 2021-11-29

Locations

1 site across 1 country: Italy